WebSep 29, 2024 · BioSyent climbed a long way after the early 2024 pandemic pullback. The stock went from about $3.20 to $8.00 before the year was out. But 2024 has been a bit of a bust so far, with the stock ... WebMar 24, 2024 · BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It owns a legacy business that manufactures and markets Protect-It, a bio-friendly non-toxic product used in agriculture, which is operated by its subsidiary Hedley Technologies Ltd.
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor …
WebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … WebMar 9, 2024 · Investor Takeaway. BioSyent appears to be fairly valued. The company is expected to report Q4 earnings on March 21, 2024, and it will be important to see the percentage growth of FeraMAX sales in ... orchidea bouquet
BioSyent: A Great Micro Cap (OTCMKTS:BIOYF) Seeking Alpha
WebFeb 1, 2024 · Article content. MISSISSAUGA, Ontario, Feb. 01, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on March 15, 2024, to shareholders of record at the close of … WebFeb 24, 2024 · 1.3% of BioSyent shares are held by institutional investors. 40.6% of BioSyent shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. WebBioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … ir thicket\\u0027s